Clinical Trials Logo
  1. Home
  2. Neuralgia, Postherpetic
  3. NCT00282763

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Neuralgia, Postherpetic Clinical Trial

Official title:
Proprietary Information - Exploratory (Non-confirmatory) Trial

Clinical Trial Summary

The purpose of this Study is to test the Safety and Effectiveness of MK0686 in relieving neuropathic (chronic) pain as experienced by patients with Postherpetic Neuralgia (Also Know as PHN or Post Shingles Pain).

This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00282763
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Terminated
Phase Phase 2
Start date December 2005
Completion date August 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT02484170 - Mannitol Cream for Post Herpetic Neuralgia Phase 1/Phase 2
Terminated NCT00964990 - A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia) Phase 2
Completed NCT00394901 - A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia Phase 3
Completed NCT01252160 - Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage Phase 4
Completed NCT00377598 - Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia Phase 2/Phase 3
Completed NCT00160667 - A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) Phase 2
Terminated NCT00245544 - Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) Phase 2
Completed NCT00335933 - Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Phase 3
Completed NCT00617461 - A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment Phase 2
Withdrawn NCT02426411 - Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN Phase 2
Completed NCT01129531 - A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia Phase 2
Completed NCT00674687 - A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing N/A
Terminated NCT01678924 - A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia Phase 2
Completed NCT00424372 - A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia Phase 3
Completed NCT00619476 - A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN) Phase 2
Terminated NCT00295776 - Lamictal in the Treatment of Post-Herpetic Neuralgia Phase 2/Phase 3
Completed NCT00570310 - Neuropathic Pain Syndrome Patient Study (MK-0000-072) Phase 1
Completed NCT00568321 - RN624 For Pain Of Post-Herpetic Neuralgia Phase 2
Not yet recruiting NCT01102101 - Effect of Opioids in Neuropathic Pain in Postherpetic Patients Phase 3
Completed NCT00614705 - PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia Phase 2